Langerhans cell histiocytosis: A reactive or neoplastic disorder? [1]

Medical and Pediatric Oncology

Volumn 37, Issue 6, 2001, Pages 543-544

  Zelger, Bernhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW CELL; BONE MARROW DEPRESSION; CELL CLONE; CELL DIFFERENTIATION; CELL STRUCTURE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC DISORDER; HISTIOCYTOSIS X; HUMAN; IMMUNE DEFICIENCY; LETTER; LIVER DYSFUNCTION; MYELODYSPLASIA; PRIORITY JOURNAL;

HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS;

EID: 0035180726     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1249     Document Type: Letter

References (9)

1. Concurrent Langerhans cell histiocytosis and myelodysplasia in children
2. Commentary. Is Langerhans cell histiocytosis a myeloid dendritic stem cell disorder related to myelodysplastic disorders?
3. Controversies and new approaches to treatment of Langerhans cell histiocytosis
4. Familial clustering of Langerhans cell histiocytosis
5. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-malignancy study group of the histiocyte society
6. Langerhans cell histiocytosis pathobiology and pathogenesis
7. Langerhans cell Histiocytosis: Familial clusters and impact on understanding its etiology
8. Langerhans cell histiocytosis (Histiocytosis X): A clonal proliferative disease
9. Detection of expanded T cell clones in skin biopy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays